The Malaria Grant New Fund Model 3

---

Implementer: Ministry of Health - Government of Malawi  |  Funding: MWK   58981176

---

1. About the Grant

The grant is implemented by the Ministry of Health, responsible for interventions at primary, secondary and tertiary health facilities (bio-medical – mainly case management and at community level (iCCM). It is also responsible for LLIN routine and mass campaign distribution of and health systems strengthening with a total grant amount of US$ 58,981,176.

2. Goals:

To reduce malaria incidence from a 2016 baseline of 386 per 1000 population to 129/1000 population in 2024 and to reduce malaria deaths from 23 per 100,000 populations to 7/100,000 population by 2024.

---

3. Target Group/Beneficiaries:

• The general population;
• Pregnant women;
• Children under 5 years.

---

4. Strategies:

• Ensure 100% coverage for prompt and effective first and second-line treatment (ACT and injectable artesunate) to reduce malaria morbidity and mortality;
• Ensure uninterrupted availability of malaria commodities at all service points by 2022;
• Expand iCCM at community level to reduce presumptive diagnosis through the use of RDTs at the community level, enhance data utilization by Health Surveillance Assistants (HSAs);
• To increase proportion of caregivers of under-five children who take action to seek appropriate malaria treatment within 24 hours of the onset of fever from 31.2% to 50% by June 2024;
• By 2024, at least 90% of the population use one or more malaria preventative interventions;
• Strengthen Monitoring and Evaluation systems to enable accurate data reporting, improve prioritization of malaria interventions and accountability for proper commodity use at the facility and community levels. 

---

5. Planned Activities:

• Procure case management commodities including (ACT, RDT, artesunate injectables);
• Procure LLINs for the 2021 mass campaign;
• Conduct case management refresher trainings at district level;
• Perform data quality audits;
• Conduct Malaria Data Review Meetings at zonal and district levels;
• Support the implementation of DHIS II;
• Conduct drug efficacy studies;
• Conduct entomological profile and insecticide resistance studies;
• Conduct quarterly post marketing surveillance;
• Performing quality assurance and quality control of malaria drugs.